Cargando…
Neurofibromatosis: Molecular Pathogenesis and Natural Compounds as Potential Treatments
The neurofibromatosis syndromes, including NF1, NF2, and schwannomatosis, are tumor suppressor syndromes characterized by multiple nervous system tumors, particularly Schwann cell neoplasms. NF-related tumors are mainly treated by surgery, and some of them have been treated by but are refractory to...
Autores principales: | Amaravathi, Anusha, Oblinger, Janet L., Welling, D. Bradley, Kinghorn, A. Douglas, Chang, Long-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485038/ https://www.ncbi.nlm.nih.gov/pubmed/34604034 http://dx.doi.org/10.3389/fonc.2021.698192 |
Ejemplares similares
-
LIM Domain Kinases as Potential Therapeutic Targets for Neurofibromatosis Type 2
por: Petrilli, Alejandra, et al.
Publicado: (2013) -
Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
por: Welling, D. Bradley, et al.
Publicado: (2021) -
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches
por: Geissler, Klaus
Publicado: (2021) -
Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways
por: Wang, Mingchuan, et al.
Publicado: (2022) -
New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)